Literature DB >> 6616960

Abnormalities of lymphocyte locomotion in immunodeficiency disease.

D E Van Epps, A El-Naggar, H D Ochs.   

Abstract

Lymphocyte and neutrophil locomotion were studied in 23 patients with well defined, primary immunodeficiencies. These included eight patients with common variable immune deficiency, three patients with X-linked agammaglobulinaemia, two patients with the Wiskott-Aldrich syndrome, three patients with ataxia telangiectasia, three patients with immunodeficiency and normal serum immunoglobulin concentrations, one patient with immune deficiency and hyper-IgM syndrome, two patients with Job syndrome and one patient with a granulocyte adherence defect. Random and stimulated lymphocyte and neutrophil migration were evaluated. C5a and casein were used to stimulate lymphocyte migration and C5a and formyl-methionyl-leucyl-phenylalanine (f-MLP) were used to stimulate neutrophil migration. Significantly depressed lymphocyte migration in response to casein and C5a was observed in patients with common variable immune deficiency, patients with immune deficiency and normal immunoglobulin concentration, and patients with Job syndrome. No consistent defect in lymphocyte locomotion was observed in the other patients studied. Neutrophil migration in response to C5a and f-MLP was depressed in Job syndrome, the patient with a granulocyte adherence defect, one of the six patients with common variable immune deficiency and none of the remaining patients. No significant correlation of skin test reactivity and lymphocyte migration was noted, but a correlation between the degree of lymphocyte proliferation in response to phytohaemagglutinin and lymphocyte migration in response to casein was observed. The results presented indicate that aberrations in lymphocyte migration occur in several types of immunodeficiency diseases and that defects in lymphocyte and neutrophil migration can occur simultaneously or totally independent of each other.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616960      PMCID: PMC1535631     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

2.  Chemotaxis of mitogen-activated human lymphocytes and the effects of membrane-active enzymes.

Authors:  P C Wilkinson; J A Roberts; R J Russell; M McLoughlin
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

3.  Heterogeneity of locomotion in human T cell subsets.

Authors:  D M Parrott; R A Good; G J O'Neill; S Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Locomotion of human lymphoid cells. I. Effect of culture and con A on T and non-T lymphocytes.

Authors:  G J O'Neill; D M Parrott
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

5.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.

Authors:  S D Davis; J Schaller; R J Wedgwood
Journal:  Lancet       Date:  1966-05-07       Impact factor: 79.321

6.  Defective neutrophil chemotaxis in hypogammaglobulinemia and selective IgA deficiency.

Authors:  R D'Amelio; P Rossi; S Le Moli; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1980-07

7.  Subpopulations of human T lymphocytes. VIII. Locomotion of lymphocyte subpopulations in patients with primary immunodeficiency disorders.

Authors:  S Gupta; A Miescher; R A Good
Journal:  Thymus       Date:  1979-09

8.  Chemotaxis of rat lymphocytes.

Authors:  P A Ward; E R Unanue; S J Goralnick; G F Schreiner
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

9.  Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia.

Authors:  H M Grey; E Rabellino; B Pirofsky
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.

Authors:  J S Goodwin; R P Messner; G T Peake
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  2 in total

1.  Genetic linkage of hyper-IgE syndrome to chromosome 4.

Authors:  B Grimbacher; A A Schäffer; S M Holland; J Davis; J I Gallin; H L Malech; T P Atkinson; B H Belohradsky; R H Buckley; F Cossu; T Español; B Z Garty; N Matamoros; L A Myers; R P Nelson; H D Ochs; E D Renner; N Wellinghausen; J M Puck
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients.

Authors:  Andreas Cederlund; Marie Olliver; Rokeya Sultana Rekha; Monica Lindh; Lennart Lindbom; Staffan Normark; Birgitta Henriques-Normark; Jan Andersson; Birgitta Agerberth; Peter Bergman
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.